Cargando…

Correction: Impella versus IABP in acute myocardial infarction complicated by cardiogenic shock

Detalles Bibliográficos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2019
Materias:	Correction
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6593194/ https://www.ncbi.nlm.nih.gov/pubmed/31297229 http://dx.doi.org/10.1136/openhrt-2018-000987corr1

Ejemplares similares

Impella versus IABP in acute myocardial infarction complicated by cardiogenic shock
por: Alushi, Brunilda, et al.
Publicado: (2019)

IABP versus Impella Support in Cardiogenic Shock: “In Silico” Study
por: De Lazzari, Beatrice, et al.
Publicado: (2023)

Beneficial Effects of IABP in Anterior Myocardial Infarction Complicated by Cardiogenic Shock
por: Somaschini, Alberto, et al.
Publicado: (2023)

Impella to Treat Acute Myocardial Infarct-Related Cardiogenic Shock
por: Møller, Jacob Eifer, et al.
Publicado: (2022)

BNP and NT-proBNP in patients with acute myocardial infarction complicated by cardiogenic shock: results from the IABP Shock trial
por: Lemm, H, et al.
Publicado: (2010)

Complications and Outcomes of Impella Treatment in Cardiogenic Shock Patients With and Without Acute Myocardial Infarction
por: Saito, Yuichi, et al.
Publicado: (2023)

Pre-PCI versus immediate post-PCI Impella initiation in acute myocardial infarction complicated by cardiogenic shock
por: Hemradj, Veemal V., et al.
Publicado: (2020)

Fibroblast growth factor 23 in acute myocardial infarction complicated by cardiogenic shock: a biomarker substudy of the Intraaortic Balloon Pump in Cardiogenic Shock II (IABP-SHOCK II) trial
por: Fuernau, Georg, et al.
Publicado: (2014)

Clopidogrel vs. prasugrel vs. ticagrelor in patients with acute myocardial infarction complicated by cardiogenic shock: a pooled IABP-SHOCK II and CULPRIT-SHOCK trial sub-analysis
por: Orban, Martin, et al.
Publicado: (2021)

The Current Use of Impella 2.5 in Acute Myocardial Infarction Complicated by Cardiogenic Shock: Results from the USpella Registry
por: O’Neill, William W, et al.
Publicado: (2014)

Cardiogenic Shock Complicating Acute Myocardial Infarction Treated With Percutaneous Coronary Intervention Supported by Impella: Implications of Advanced Age and Refractory Shock on Outcomes
por: Boshara, Andrew, et al.
Publicado: (2021)

Impella versus Venoarterial Extracorporeal Membrane Oxygenation for Acute Myocardial Infarction Cardiogenic Shock: A Systematic Review and Meta-Analysis
por: Batchelor, Riley J., et al.
Publicado: (2022)

Support with Impella versus intra-aortic balloon pump in acute myocardial infarction complicated by cardiogenic shock: A protocol for systematic review and meta-analysis
por: Rao, Lingzhang, et al.
Publicado: (2021)

Cardiogenic shock after ST elevation myocardial infarction and IABP-SHOCK II risk score validation in a cohort treated with pharmacoinvasive strategy
por: Moraes, Pedro Ivo M, et al.
Publicado: (2019)

Contemporary Management of Cardiogenic Shock Complicating Acute Myocardial Infarction
por: De Luca, Leonardo, et al.
Publicado: (2023)

Augmenting Function for Infarction from Infection: Impella 2.5 for Ischemic Cardiogenic Shock Complicating Sepsis
por: George, Praveen, et al.
Publicado: (2017)

Comparison of the Efficacy of ECMO With or Without IABP in Patients With Cardiogenic Shock: A Meta-Analysis
por: Zeng, Ping, et al.
Publicado: (2022)

Management of cardiogenic shock complicating acute myocardial infarction: A review
por: Shah, Ashish H., et al.
Publicado: (2019)

Laboratory Predictors of Prognosis in Cardiogenic Shock Complicating Acute Myocardial Infarction
por: Muzafarova, Tamilla, et al.
Publicado: (2022)

The role of the axillary Impella 5.0 device on patients with acute cardiogenic shock
por: Tarabichi, Saeed, et al.
Publicado: (2020)

Use of Impella Devices for Acute Cardiogenic Shock in the Perioperative Period of Cardiac Surgery
por: Sicouri, Serge, et al.
Publicado: (2023)

Influence of Timing and Predicted Risk on Mortality in Impella-Treated Infarct-Related Cardiogenic Shock Patients
por: Schäfer, Andreas, et al.
Publicado: (2020)

Complete Revascularisation in Impella-Supported Infarct-Related Cardiogenic Shock Patients Is Associated With Improved Mortality
por: Schäfer, Andreas, et al.
Publicado: (2021)

Real-life use of left ventricular circulatory support with Impella in cardiogenic shock after acute myocardial infarction: 12 years AMC experience
por: Ouweneel, Dagmar M, et al.
Publicado: (2018)

Sex disparities in acute kidney injury complicating acute myocardial infarction with cardiogenic shock
por: Vallabhajosyula, Saraschandra, et al.
Publicado: (2019)

Impella CP use in patients with non‐ischaemic cardiogenic shock
por: Maniuc, Octavian, et al.
Publicado: (2019)

Ventricular Unloading Using the Impella(TM) Device in Cardiogenic Shock
por: Attinger-Toller, Adrian, et al.
Publicado: (2022)

Usefulness of Impella support in different clinical settings in cardiogenic shock
por: Barrionuevo-Sánchez, María Isabel, et al.
Publicado: (2022)

Concomitant Use of VA-ECMO and Impella Support for Cardiogenic Shock
por: Modi, Shan P., et al.
Publicado: (2023)

A Review of Cardiogenic Shock in Acute Myocardial Infarction
por: Khalid, L, et al.
Publicado: (2008)

Paraganglioma masquerading as acute myocardial infarction and cardiogenic shock
por: Ahmad, Tanveer, et al.
Publicado: (2016)

Hemodynamic Support Using Percutaneous Transfemoral Impella 5.0 and Impella RP for Refractory Cardiogenic Shock
por: Dalal, Pratik K., et al.
Publicado: (2019)

ST-Elevation Myocardial Infarction With Cardiogenic Shock and Severe Acute Ischemic Mitral Regurgitation Rescued by Primary Coronary Intervention Under Hemodynamic Support With Impella
por: Koiwaya, Hiroshi, et al.
Publicado: (2021)

Predictors of outcome after primary PTCA for acute myocardial infarction complicated by cardiogenic shock
por: Krakau, I, et al.
Publicado: (1999)

Clinical review: mechanical circulatory support for cardiogenic shock complicating acute myocardial infarction
por: Cove, Matthew E, et al.
Publicado: (2010)

Effect of Early Statin Treatment in Patients with Cardiogenic Shock Complicating Acute Myocardial Infarction
por: Sim, Doo Sun, et al.
Publicado: (2013)

Challenges in the conduct of randomised controlled trials in cardiogenic shock complicating acute myocardial infarction
por: Freund, Anne, et al.
Publicado: (2022)

Prognostic Factors of In-Hospital Mortality in Patients with Acute Myocardial Infarction Complicated by Cardiogenic Shock
por: Sato, Takanori, et al.
Publicado: (2022)

Impella versus extracorporal life support in cardiogenic shock: a propensity score adjusted analysis
por: Wernly, Bernhard, et al.
Publicado: (2021)

Use of Impella heart pump for management of women with peripartum cardiogenic shock
por: Elkayam, Uri, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_a7ue5vv2mb8571t38335kvglb4